Locus Biosciences

Locus Biosciences: Series C Funding Round

Locus Biosciences has successfully raised $152M in Series C funding, reaching a valuation of $600M.

Company Overview

CRISPR-edited bacteriophages

Funding Details

The Series C round was led by Johnson & Johnson, with participation from Longitude Capital, Braeburn Capital, Domain Associates.

Company Information

• Headquarters: 9201 University City Boulevard, Charlotte, NC 28223
• Founded: 2015
• Employees: 150+
• Category: Biotech

Investment

Locus Biosciences plans to use the funds to accelerate product development, expand its team, and scale operations globally.

About the Investors

• Johnson & Johnson: Verified investor in Series C
• Longitude Capital: Verified investor in Series C
• Braeburn Capital: Verified investor in Series C
• Domain Associates: Verified investor in Series C